🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Kansas › Overland Park

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Overland Park, KS

3 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan ak bò kote Overland Park (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Ap rekriteFaz 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

Ap rekriteFaz 3
  • University of Kansas Cancer Center-Overland Park, Overland Park
  • University of Kansas Hospital-Indian Creek Campus, Overland Park
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07441681

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • The University of Kansas Cancer Center - Indian Creek Campus, Overland Park
  • The University of Kansas Cancer Center, Investigational Drug Services, Fairway · 3 mi lwen
  • The University of Kansas Clinical Research Center, Fairway · 3 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Etid Karsinòm selil skuamèz tèt ak kou nan lòt vil

Lòt etid nan Overland Park

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.